Premature menopause. Primary ovarian failure
Conditions
Interventions
Women diagnosed with premature menopause by a specialist physician, aged between 28 and 35 years, will be enrolled in this study after completing the informed consent form. These participants will und
Sponsors
Birjand University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
28 Years to 35 Years
Inclusion criteria
Inclusion criteria: Age range 28-35 Confirmation of premature menopause by a specialist doctor Absence of uterine and ovarian problems Absence of hormonal, cancer and autoimmune diseases Not taking antidepressants and anti-stress medications
Exclusion criteria
Exclusion criteria: Presence of uncontrolled chronic diseases such as heart or kidney failure. Recent history of pelvic or uterine surgery. Severe psychiatric disorders interfering with study participation. Use of medications affecting the hypothalamic-pituitary-ovarian axis. Lack of willingness or inability to complete study follow-up. Any medical condition deemed unsuitable for participation by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Follicle Stimulating Hormone (FSH) measurement. Timepoint: Before and after the intervention. Method of measurement: VIDAS system.;Estradiol measurement. Timepoint: Before and after the intervention. Method of measurement: VIDAS system.;Anti-Müllerian Hormone ( AMH) measurement. Timepoint: Before and after the intervention. Method of measurement: VIDAS system.;Antral Follicle Count ( AFC). Timepoint: Before and after the intervention. Method of measurement: Ultrasound. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAtena Mansouri
Birjand University of Medical Sciences
Outcome results
None listed